{"entity":{"id":"nct05381103","kind":"trial","name":"PSMA-PET to Guide Prostatectomy","aka":[],"tldr":"A phase 2/3 trial of an investigational treatment in prostate cancer, run by Five Eleven Pharma, Inc., now recruiting.","summary":"PSMA-PET to Guide Prostatectomy is a phase 2/3 interventional study registered as NCT05381103 by Five Eleven Pharma, Inc., with 288 participants planned, started 2021-10-01 and due to reach its primary completion in 2028-06-01.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05381103","url":"https://clinicaltrials.gov/study/NCT05381103"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT05381103","phase":"2/3","setting":"PSMA-PET to Guide Prostatectomy: A Randomized Trial","sponsor":"Five Eleven Pharma, Inc.","enrolled":288,"outcomes":[]},"route":"/trials/nct05381103/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}]}}